Australia Markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
23.66+0.67 (+2.91%)
At close: 04:00PM EDT
23.66 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 687.96M
Enterprise value 394.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.39
Price/book (mrq)0.61
Enterprise value/revenue 1.37
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.37
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 344.09
52-week low 318.91
50-day moving average 320.94
200-day moving average 323.80

Share statistics

Avg vol (3-month) 3179.39k
Avg vol (10-day) 3266.2k
Shares outstanding 529.92M
Implied shares outstanding 6N/A
Float 819.8M
% held by insiders 132.51%
% held by institutions 150.88%
Shares short (15 July 2024) 4784k
Short ratio (15 July 2024) 44.24
Short % of float (15 July 2024) 44.76%
Short % of shares outstanding (15 July 2024) 42.62%
Shares short (prior month 14 June 2024) 4783.38k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -57.71%
Operating margin (ttm)-33.80%

Management effectiveness

Return on assets (ttm)-3.34%
Return on equity (ttm)-14.46%

Income statement

Revenue (ttm)287.53M
Revenue per share (ttm)9.64
Quarterly revenue growth (yoy)-2.50%
Gross profit (ttm)N/A
EBITDA -43.74M
Net income avi to common (ttm)-165.95M
Diluted EPS (ttm)-5.56
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)305.7M
Total cash per share (mrq)10.22
Total debt (mrq)13.56M
Total debt/equity (mrq)1.20
Current ratio (mrq)5.09
Book value per share (mrq)37.80

Cash flow statement

Operating cash flow (ttm)42.18M
Levered free cash flow (ttm)15.53M